New Thyroid Cancer Diagnostics & Theranostic Approaches with Dr. Gulec

Published 2024-04-12

We are honored to have Dr. Seza Gulec present "A Joint Statement from the ATA, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer." Dr. Marcin Barczynski joins as the featured expert discussant. Our sincere gratitude to Dr. Munir Ghesani, our special guest moderator this week.

0:00 Webinar

2:47 Dr. Gulec presents

2:47 Theranostic Approaches In Thyroid Cancer
Dr. Gulec introduces the "Martinique Initiative," a framework led by top thyroid cancer leaders to discuss controversial topics and foster evidence-based discussions. This initiative results in the "Martinique Principles," guiding the use of Radioactive Iodine (I-131) in thyroid cancer management and providing insights into its optimal therapeutic use.

7:50 Peri-Operative Risk Stratification In Thyroid Cancer
Dr. Gulec explores the "Martinique Principles" using a three-pronged approach focusing on risk classification in operative settings. He discusses survival and recurrence probabilities based on American Thyroid Association and American Joint Committee on Cancer guidelines. He proposes molecular theranostics as a tool for evaluating surgical roles in cancer management, emphasizing its utility in detecting critical genes and informing diagnosis, monitoring, and treatment decisions.

33:45 Diagnostic RAI Imaging In Initial Staging
Dr. Gulec discusses the need for improved sensitivity in imaging techniques due to evidence that pre-ablation diagnostic Radioactive Iodine (RAI) imaging is not fully effective, particularly in BRAF-like tumors with small nodal metastases. He highlights the risks of misinterpreting focal remnants as nodal disease, which can lead to incorrect upstaging in thyroid cancer risk categories.

43:15 Dr. Barczynski presents

49:00 Surgical Management & Risk Stratification
Dr. Barczynski argues for integrating risk stratification into surgical treatment strategies for thyroid cancer. He emphasizes collaboration between American and European Thyroid Associations and the Society of Nuclear Medicine and Molecular Imaging, advocating for expanded use of molecular theranostics in initial patient management.

52:01 Discussion with Q&A

** Check out our other programs! **

The THANC Guide
thancguide.org/

TIRO: Thyroid Int'l Recommendations Online
tiro.expert/

** Follow us on Twitter! **
@thancfoundation - shorturl.at/puwS0

THANC on FB - shorturl.at/svNY4